Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
  1. 4 Open-market sale Chief Financial Officer sold 3,684 shares at $1.22 ($4,494)
  2. 4 Open-market sale President and CEO sold 7,150 shares at $1.79 ($12,799)
  3. 4 Open-market sale Chief Financial Officer sold 3,171 shares at $1.78 ($5,644)
  4. 4 Open-market sale President and CEO sold 13,427 shares at $1.83 ($24,571)
  5. 4 Open-market sale Chief Financial Officer sold 4,304 shares at $1.83 ($7,863)
  6. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $2.02 ($40,400)
  7. 4 Open-market sale President and CEO sold 13,505 shares at $2.69 ($36,328)
  8. 4 Open-market sale Chief Financial Officer sold 4,320 shares at $2.69 ($11,621)
  9. 4 Open-market sale Chief Financial Officer sold 3,660 shares at $2.76 ($10,102)
  10. 4 Open-market sale President and CEO sold 12,565 shares at $2.77 ($34,805)
  11. 4 Open-market sale President and CEO sold 294,494 shares at $2.89 ($851,088)
  12. 4 Open-market sale Chief Financial Officer sold 48,366 shares at $2.89 ($139,778)
  13. 4 Open-market sale Director sold 200,000 shares at $2.99 ($598,000)
  14. 4 Grant or award Director acquired 253,429 shares (grant or award)
  15. 4 Grant or award Director acquired 253,429 shares (grant or award)
  16. 4 Grant or award Director acquired 253,429 shares (grant or award)
  17. 4 Open-market buy Chief Financial Officer bought 15,000 shares at $3.43 ($51,435)
  18. 4 Open-market buy Chief Financial Officer bought 15,000 shares at $3.22 ($48,285)
  19. 4 Option exercise 10% owner acquired 7,130,806 shares (option exercise)
  20. 3 Insider Initial Statement of Ownership

Page 3 of 13 · 243 filings